Department of Health and Human Services (DHHS)

National Institutes of Health (NIH)


Preliminary Workshop Agenda

Borderline Ovarian Tumor Consensus Workshop


Sponsors:

NIH Office of Rare Diseases

NCI Office of Women's Health

NCI Cancer Diagnosis Program


Organizers:

Jules J. Berman, Ph.D., M.D.

Steven Silverberg, M.D.


Hyatt Regency Bethesda

Bethesda, Maryland

August 27-28, 2003



Wednesday, August 27, 2003


12:30 p.m.  Registration

     

1:00 p.m.   Welcome/Administrative Issues/Charge to Workshop

   Dr. Jules Berman


1:15  p.m.   Workshop Overview 

   Dr. Steven Silverberg


Presentations


The purpose of each presentation is to focus the group on consensus issues and consensus strategies.  The presentations are not designed as subject reviews or as arguments in support of any viewpoint.


1:30 p.m.   Borderline Ovarian Tumors - Clinical Perspective

   Dr. Larry Copeland

      

2:00 p.m.    Borderline Ovarian Tumors - Molecular Biologist's

Perspective 

   Drs. Kathleen Cho, Michael Birrer


2:30 p.m.             Borderline Ovarian Tumors - Data/Study Design Perspective 

   Dr. Mark Sherman


2:45 p.m.             Open Discussion 

   Panel - Drs Copeland, Cho,  Birrer, Sherman 

  

3:05 p.m.   Break


3:15 p.m.             Micropapillary variant 

   Dr. Jeff Seidman


3:45 p.m.             Tumor implants  

   Drs. Robert Kurman and Debra Bell


4:40 p.m.   Open discussion

   Panel - Drs. Seidman, Kurman, Bell, Young, Silva


5:15 p.m.             Mucinous tumors

   Dr. Brigitte Ronnett


5:45 p.m.             Discussion/Questions

   Panel - Drs. Ronnett, Silverberg, Silva


6:00 p.m.             Adjournment for day 1

   Dr. Berman


Thursday, August 28, 2003


8:00 a.m.  Focus session  (Preliminary Consensus Items) 

                                    Drs. Young, Silva, Kurman, Silverberg, Seidman  

  

9:00 a.m.     Breakout Sessions

   Serous -  Dr. Steven Silverberg (leader)

   Mucinous - Dr. Brigette Ronnett (leader)


10:00   Break/Hotel Check-Out

 

10:30   Breakout Sessions Continue


Noon   Working Lunch 

  

1:30 p.m.   Presentations from Breakout Session Leaders with open

discussion

   (Drs Silverberg and Ronnett, with Dr. Robert Young, moderator)


2:30 p.m.         Publication plans (with Dr. Fred Gorstein)

   Final review of day's accomplishments (Dr. Jules Berman)


3:00 p.m.  Travel announcements and adjournment

   Dr. Jules Berman










key words: lmp, bot, ovarian cancer, ovarian carcinoma, benign, nci, nih, gynecology, gyn pathology, cancer research, cancer diagnosis, overtreatment, treatment, metastasis, implantation, ovary, ovaries, epithelial
Contact person: Dr. Jules Berman, Jules J. Berman, bermanj@mail.nih.gov
Date: August 27, 28, 2003
Link to Workshop summary: pending
URL: http://65.222.228.150/jjb/agenda2.htm